The prevalence of type 2 diabetes mellitus is increasing in both sexes, but men are usually
diagnosed at a younger age and lower body fat mass than women. Worldwide, an estimated …

In medicine, there is growing evidence that gender differences are important and lead to
variations in the pathophysiology and treatment of many diseases with traits that appear to …

BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

Epidemiological studies have implied that diabetes mellitus (DM) will become an epidemic
accompany with metabolic and endocrine disorders worldwide. Most of DM patients are …

Gender medicine is the first step of personalized medicine and patient-centred care, an
essential development to achieve the standard goal of a holistic approach to patients and …

Sex characteristics exhibit significant disparities in various human diseases, including
prevalent cardiovascular diseases, cancers, metabolic disorders, autoimmune diseases …

Clinical and preclinical interest in Type 2 diabetes (T2D)-associated cognitive dysfunction
(TDACD) has grown in recent years. However, the precise mechanisms underlying TDACD …

Background Randomized controlled trials showed that newer glucose‐lowering agents are
cardioprotective, but most participants were men. It is unknown whether benefits are similar …

Nearly all diseases in humans, to a certain extent, exhibit sex differences, including
differences in the onset, progression, prevention, therapy, and prognosis of diseases …

Patients with Type 2 diabetes mellitus (T2DM) frequently exhibit a distinctive cardiac
phenotype known as diabetic cardiomyopathy. Cardiac complications associated with T2DM …